Champions Oncology Inc (STU:2I3)
€ 4 0.1 (2.56%) Market Cap: 55.93 Mil Enterprise Value: 59.94 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 72/100

Q3 2020 Champions Oncology Inc Earnings Call Transcript

Mar 12, 2020 / NTS GMT
Release Date Price: €4.16 (-2.35%)
Operator

Greetings and welcome to Champion's Oncology's fourth-quarter fiscal year 2019 earnings call. (Operator Instructions)

As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host, Ronnie Morris, CEO. Please go ahead.

Ronnie Morris
Champions Oncology, Inc. - President & CEO

Good afternoon. I am Ronnie Morris, CEO of Champions Oncology. Joining me today is David Miller, our Chief Financial Officer. Thank you for joining us for our quarterly earnings call.

Before we begin, I will remind you that we'll be making forward-looking statements during today's call, and that actual results could differ materially from what you've just heard. Additional information on factors that could cause results to differ is available in our Forms 10-Q and Form 10-K. A reconciliation of non-GAAP financial measures that may be discussed during the call to GAAP financial measures is available in the earnings release.

Overall, we had another good quarter, and the theme for this call will be similar to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot